Scott T Micek1, Maanasi Samant2, Thomas Bailey3, Yixin Chen4, Chenyang Lu4, Kevin Heard5, Marin H Kollef6. 1. Department of Pharmacy Practice, St. Louis College of Pharmacy, St. Louis, Missouri. 2. Department of Internal Medicine, Washington University, St. Louis, Missouri. 3. Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri. 4. School of Engineering and Applied Sciences, Washington University in St. Louis, St. Louis, Missouri. 5. Center for Clinical Excellence, BJC HealthCare, St. Louis, Missouri. 6. Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, Missouri. mkollef@dom.wustl.edu.
Abstract
INTRODUCTION: Clinical deterioration alerts (CDAs) are increasingly employed to identify deteriorating patients. METHODS: We performed a retrospective study to determine whether CDAs predict 30-day readmission. Patients admitted to 8 general medicine units were assessed for all-cause 30-day readmission. RESULTS: Among 3015 patients, 567 (18.8%) were readmitted within 30 days. Patients triggering a CDA (n = 1141; 34.4%) were more likely to have a 30-day readmission (23.6% vs 15.9%; P < 0.001). Logistic regression identified triggering of a CDA to be independently associated with 30-day readmission (odds ratio [OR]: 1.40; 95% confidence interval [CI]: 1.26-1.55; P = 0.001). Other predictors were: an emergency department visit in the previous 6 months (OR: 1.23; 95% CI:, 1.20-1.26; P < 0.001), increasing age (OR: 1.01; 95% CI: 1.01-1.02; P = 0.003), presence of connective tissue disease (OR: 1.63; 95% CI: 1.34-1.98; P = 0.012), diabetes mellitus with end-organ complications (OR: 1.23; 95% CI: 1.13-1.33; P = 0.010), chronic renal disease (OR: 1.16; 95% CI: 1.08-1.24; P = 0.034), cirrhosis (OR: 1.25; 95% CI: 1.17-1.33; P < 0.001), and metastatic cancer (OR: 1.12; 95% CI: 1.08-1.17; P = 0.002). Addition of the CDA to the other predictors added only modest incremental value for the prediction of hospital readmission. CONCLUSIONS: Readily identifiable clinical variables can be identified that predict 30-day readmission. It may be important to include these variables in existing prediction tools if pay for performance and across-institution comparisons are to be "fair" to institutions that care for more seriously ill patients. Journal of Hospital Medicine 2016;11:768-772.
INTRODUCTION: Clinical deterioration alerts (CDAs) are increasingly employed to identify deteriorating patients. METHODS: We performed a retrospective study to determine whether CDAs predict 30-day readmission. Patients admitted to 8 general medicine units were assessed for all-cause 30-day readmission. RESULTS: Among 3015 patients, 567 (18.8%) were readmitted within 30 days. Patients triggering a CDA (n = 1141; 34.4%) were more likely to have a 30-day readmission (23.6% vs 15.9%; P < 0.001). Logistic regression identified triggering of a CDA to be independently associated with 30-day readmission (odds ratio [OR]: 1.40; 95% confidence interval [CI]: 1.26-1.55; P = 0.001). Other predictors were: an emergency department visit in the previous 6 months (OR: 1.23; 95% CI:, 1.20-1.26; P < 0.001), increasing age (OR: 1.01; 95% CI: 1.01-1.02; P = 0.003), presence of connective tissue disease (OR: 1.63; 95% CI: 1.34-1.98; P = 0.012), diabetes mellitus with end-organ complications (OR: 1.23; 95% CI: 1.13-1.33; P = 0.010), chronic renal disease (OR: 1.16; 95% CI: 1.08-1.24; P = 0.034), cirrhosis (OR: 1.25; 95% CI: 1.17-1.33; P < 0.001), and metastatic cancer (OR: 1.12; 95% CI: 1.08-1.17; P = 0.002). Addition of the CDA to the other predictors added only modest incremental value for the prediction of hospital readmission. CONCLUSIONS: Readily identifiable clinical variables can be identified that predict 30-day readmission. It may be important to include these variables in existing prediction tools if pay for performance and across-institution comparisons are to be "fair" to institutions that care for more seriously ill patients. Journal of Hospital Medicine 2016;11:768-772.
Authors: Ruben Amarasingham; Billy J Moore; Ying P Tabak; Mark H Drazner; Christopher A Clark; Song Zhang; W Gary Reed; Timothy S Swanson; Ying Ma; Ethan A Halm Journal: Med Care Date: 2010-11 Impact factor: 2.983
Authors: Amber M Sawyer; Eli N Deal; Andrew J Labelle; Chad Witt; Steven W Thiel; Kevin Heard; Richard M Reichley; Scott T Micek; Marin H Kollef Journal: Crit Care Med Date: 2011-03 Impact factor: 7.598
Authors: Thomas C Bailey; Yixin Chen; Yi Mao; Chenyang Lu; Gregory Hackmann; Scott T Micek; Kevin M Heard; Kelly M Faulkner; Marin H Kollef Journal: J Hosp Med Date: 2013-02-25 Impact factor: 2.960
Authors: Steven W Thiel; Jamie M Rosini; William Shannon; Joshua A Doherty; Scott T Micek; Marin H Kollef Journal: J Hosp Med Date: 2010-01 Impact factor: 2.960
Authors: Charles A Baillie; Christine VanZandbergen; Gordon Tait; Asaf Hanish; Brian Leas; Benjamin French; C William Hanson; Maryam Behta; Craig A Umscheid Journal: J Hosp Med Date: 2013-11-13 Impact factor: 2.960
Authors: Christopher R King; Joanna Abraham; Thomas G Kannampallil; Bradley A Fritz; Arbi Ben Abdallah; Yixin Chen; Bernadette Henrichs; Mary Politi; Brian A Torres; Angela Mickle; Thaddeus P Budelier; Sherry McKinnon; Stephen Gregory; Sachin Kheterpal; Troy Wildes; Michael S Avidan Journal: F1000Res Date: 2019-11-29